pentobarbital will decrease the level or result of bedaquiline by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Stay clear of or Use Alternate Drug. Stay clear of coadministration of bedaquiline with solid CYP3A4 inducers as a result of opportunity for lessened therapeutic impactpentobarbital decreases outcomes of sufentanil SL by impactin